NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
211 Östergötland

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 651 5.2% 371 3.0% 20 0.2% . . 1 0.0% 6 0.0% 11495 91.6% 12544 100.0%
ASCUS 247 16.9% 466 31.9% 116 7.9% 1 0.1% 1 0.1% 4 0.3% 628 42.9% 1463 100.0%
LSIL 70 8.5% 302 36.6% 152 18.4% 2 0.2% 3 0.4% 5 0.6% 292 35.4% 826 100.0%
Atypical glandular cells/AGC 12 29.3% 6 14.6% 1 2.4% 5 12.2% 1 2.4% 1 2.4% 15 36.6% 41 100.0%
Unclear atypia . . 1 100.0% . . . . . . . . . . 1 100.0%
ASC-H 9 11.4% 21 26.6% 46 58.2% 2 2.5% . . . . 1 1.3% 79 100.0%
HSIL 6 2.3% 32 12.3% 202 77.7% 5 1.9% 9 3.5% . . 6 2.3% 260 100.0%
Suspected Adenocarcinom 1 5.9% . . . . 4 23.5% 4 23.5% . . 8 47.1% 17 100.0%
Malignant tumor with unclear origin . . . . . . . . 1 50.0% . . 1 50.0% 2 100.0%
Squamous cell cancer . . . . 2 40.0% . . 3 60.0% . . . . 5 100.0%
Totalt 996 6.5% 1199 7.9% 539 3.5% 19 0.1% 23 0.2% 16 0.1% 12446 81.7% 15238 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the category Cancer:
M80703, M81403, M81409, M83803, M98233